Copyright 2009 Medical News Today Latest Menopause News From Medical News Today. http://www.medicalnewstoday.com/sections/menopause/ admin@medicalnewstoday.com (MNT Admin) editors@medicalnewstoday.com (MNT Editors) en-us Sun, 29 Nov 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/172308.php http://www.medicalnewstoday.com/articles/172308.php The Swedish biotech company Karo Bio (Reuters: KARO.ST) announced that Merck & Co., Inc., through an affiliate, plans to enter a clinical phase IIa trial with the collaboration's lead investigational drug candidate, MK-6913, identified as part of their joint research collaboration. No milestone payment to Karo Bio is associated with the initiation of phase II clinical development. Menopause Fri, 27 Nov 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/172275.php http://www.medicalnewstoday.com/articles/172275.php The so-called RANK protein and the molecule that binds to it, the RANK ligand or RANKL, form a focus of the work of Josef Penninger, director of the Institute of Molecular Biotechnology (IMBA) in Vienna. In 1999 his group deleted the RANKL gene from mice and showed that the RANK/RANKL system was the "master regulator" governing bone loss (Kong et al. 1999 Nature 402, 304-309). Bones / Orthopaedics Wed, 25 Nov 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/172022.php http://www.medicalnewstoday.com/articles/172022.php Animal studies suggest that adding flaxseed oil to the diet could reduce the risk of osteoporosis in post-menopausal women and women with diabetes, according to a report to be published in the International Journal of Food Safety, Nutrition and Public Health. Mer Harvi and colleagues at the National Research Center, in Cairo, Egypt, have studied the effect of diabetes on bone health and evaluated how flaxseed oil in the diet might delay the onset of osteoporosis. Bones / Orthopaedics Wed, 25 Nov 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/172030.php http://www.medicalnewstoday.com/articles/172030.php A menopause-cardiology consensus statement has called for direct action to prevent cardiovascular disease (CVD) in menopausal women. The statement also concludes that there is little evidence of increased CVD risk in taking HRT. The International Menopause Society consensus statement was developed at a Workshop** between menopause specialists and cardiologists. The Task Force on Gender of the European Society of Cardiology participated in the Workshop. Heart Disease Sat, 14 Nov 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/170904.php http://www.medicalnewstoday.com/articles/170904.php A compound in coffee has been found to be estrogenic in studies by Texas AgriLife Research scientists. Though the studies have not been conducted to determine recommended consumption amounts, scientists say the compound, called trigonelline or "trig," may be a factor in estrogen-dependent breast cancer but beneficial against colon cancer development. "The important thing to get from this is that 'trig' has the ability to act like a hormone," said Dr. Colorectal Cancer Fri, 13 Nov 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/170892.php http://www.medicalnewstoday.com/articles/170892.php A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion. Breast Cancer Tue, 10 Nov 2009 06:00:00 PST http://www.medicalnewstoday.com/articles/170458.php http://www.medicalnewstoday.com/articles/170458.php New Mayo Clinic research has found that robotic surgery for vaginal prolapse (http://www.mayoclinic.org/pelvic-organ-prolapse/) dramatically reduces patient hospital stay and recovery time. These findings are being presented this week at the North Central Section of the American Urological Association in Scottsdale, Ariz. Women's Health / Gynecology Tue, 10 Nov 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/170315.php http://www.medicalnewstoday.com/articles/170315.php Women who have an early menopause are unlikely to have a long term increased risk of hip fractures associated with menopausal bone density weakening, according to a new study from The Australian National University. For decades medical practitioners have understood a link between menopause and a decrease in bone density. Menopause Mon, 09 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/170262.php http://www.medicalnewstoday.com/articles/170262.php Researchers in the US found that the decline in use of postmenopausal hormone therapy may partly explain the fall in incidence of a known risk factor for breast cancer, atypical ductal hyperplasia. They also said their findings support the idea that low and high grade breast cancers develop via different pathways and thereby clarify the role that hormone therapy may play in increasing the rates of breast cancer. Breast Cancer Mon, 09 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/170265.php http://www.medicalnewstoday.com/articles/170265.php The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. "Postmenopausal hormone treatment is associated with increased rates of benign breast biopsies, and early and late stages of cancer. Breast Cancer Thu, 05 Nov 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/169964.php http://www.medicalnewstoday.com/articles/169964.php For estrogen replacement to provide stroke protection, it likely must be given soon after levels drop because of menopause or surgical removal of the ovaries, scientists report in the Journal of Neuroscience. Stroke Thu, 29 Oct 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/169161.php http://www.medicalnewstoday.com/articles/169161.php Hormone replacement therapy (HRT) to treat menopausal estrogen deficiency has been in widespread use for over 60 years. Several observational studies over the years showed that HRT use by younger postmenopausal women was associated with a significant reduction in total mortality; available evidence supported the routine use of HRT to increase longevity in postmenopausal women. Menopause Fri, 23 Oct 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/168413.php http://www.medicalnewstoday.com/articles/168413.php Earlier this year, the BBC reported that "HRT - Hormone Replacement Therapy - can shrink women's brains"1, after a study was published which showed that brain volume in women taking HRT was smaller in two key areas involved in thinking and memory. Menopause Tue, 20 Oct 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/168017.php http://www.medicalnewstoday.com/articles/168017.php The right combination of estrogen and a selective estrogen receptor modulator (SERM), which blocks the effects of estrogen in breast tissue, could relieve menopause symptoms and cut breast cancer risk, Yale researchers report in an abstract presented at the American Society for Reproductive Medicine (ASRM) scientific meeting in Atlanta, Georgia, October 17-21. Breast Cancer Wed, 14 Oct 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/167205.php http://www.medicalnewstoday.com/articles/167205.php Depomed, Inc. (NASDAQ:DEPO) announced top-line results from the BREEZE 1 and 2 Phase 3 clinical trials evaluating the safety and efficacy of SeradaTM, an investigational non-hormonal extended release formulation of gabapentin for the treatment of menopausal hot flashes. In the higher dose treatment arm of the two doses evaluated, the 1800mg dose achieved positive results at 4 weeks. Menopause Tue, 13 Oct 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/167181.php http://www.medicalnewstoday.com/articles/167181.php Women who developed new-onset breast tenderness after starting estrogen plus progestin hormone replacement therapy were at significantly higher risk for developing breast cancer than women on the combination therapy who didn't experience such tenderness, according to a new UCLA study. The research, published in the Oct. Menopause Sat, 10 Oct 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/166923.php http://www.medicalnewstoday.com/articles/166923.php SE5-OH containing Natural S-equol, a novel soy germ-based ingredient in a supplement, improved menopausal symptoms, including significantly reducing hot flash frequency by nearly 59 percent, according to a peer-reviewed study in Japanese women. This key study was presented in an oral presentation at the North American Menopause Society (NAMS) 20th annual meeting. Menopause Tue, 06 Oct 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/166448.php http://www.medicalnewstoday.com/articles/166448.php Michael Holick, PhD, MD, director of the Bone Healthcare Clinic and the Vitamin D, Skin and Bone Research Laboratory at Boston University School of Medicine BUSM recently received the 2009 NAMS/Upsher-Smith Laboratories, Inc.Vitamin D Research Award from the North American Menopause Society (NAMS). Holick was presented with the award during NAMS' 20th annual meeting in San Diego, California on September 30 - October 3, 2009. NAMS/Upsher-Smith Laboratories, Inc. Menopause Thu, 01 Oct 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/165871.php http://www.medicalnewstoday.com/articles/165871.php Post-menopausal women who engage in moderate to vigorous exercise have a reduced risk of breast cancer. This comes from researchers writing the open access journal BMC Cancer who investigated the link between breast cancer and exercise. "With an estimated 182,460 new cases diagnosed in the United States in 2008, breast cancer is recognized as the most common cancer affecting U.S. women" says Dr. Tricia M Peters from the U.S. Breast Cancer Wed, 30 Sep 2009 04:00:00 PST http://www.medicalnewstoday.com/articles/165705.php http://www.medicalnewstoday.com/articles/165705.php Pre- and post-menopausal women who self-rated themselves as being sexually satisfied had a higher overall psychological well-being score and scores for "positive well-being" and "vitality," compared with sexually dissatisfied women in a study of 295 women sexually active more than twice a month. The study, published in The Journal of Sexual Medicine, also uncovered a positive association between age and well-being, but a negative association for general health. Women's Health / Gynecology Tue, 29 Sep 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/165570.php http://www.medicalnewstoday.com/articles/165570.php Researchers from Boston University School of Medicine (BUSM) are recommending that menopausal women on hormone therapy (HT) continue their treatment prior to having their annual mammogram screenings. These recommendations appear as an editorial in the current on-line issue of Journal of the North American Menopause Society. Menopause Wed, 23 Sep 2009 06:00:00 PST http://www.medicalnewstoday.com/articles/164931.php http://www.medicalnewstoday.com/articles/164931.php Researchers have identified a mechanism that may keep a well known signaling molecule from eroding bone and inflaming joints, according to an early study published online in the Journal of Clinical Investigation. Bone is continually recycled to maintain its strength through the competing action of osteoclasts, cells that break down aging bone, and osteoblasts, which build new bone. Arthritis / Rheumatology Wed, 23 Sep 2009 04:00:00 PST http://www.medicalnewstoday.com/articles/164908.php http://www.medicalnewstoday.com/articles/164908.php New research has found that switching post-menopausal women with early breast cancer to the drug exemestane (Aromasin) after two or three years of tamoxifen rather than keeping them on tamoxifen for five years improves the chance of remaining cancer free and reduces the risk of death for at least the next six years. Breast Cancer Wed, 23 Sep 2009 04:00:00 PST http://www.medicalnewstoday.com/articles/164910.php http://www.medicalnewstoday.com/articles/164910.php The largest study in the world of treatments for post menopausal, hormone positive breast cancer has shown that patients who continue to take exemestane or tamoxifen do significantly better than patients who start to take one or other drug (or tamoxifen followed exemestane) but then stop. Breast Cancer Wed, 23 Sep 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/164872.php http://www.medicalnewstoday.com/articles/164872.php Women who take hormone replacement therapy are nearly twice as likely to die from lung cancer, according to a study published in the journal Lancet, the Los Angeles Times reports. Menopause